Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Glucagon-like Peptide-1 Levels Predict In-hospital Complications in ST-segment Elevation Myocardial Infarction

NCT03314844 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT03314844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03314844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Glucagon-like Peptide-1 Levels Predict In-hospital Complications in ST-segment Elevation Myocardial Infarction
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Completed
Start date
February 1, 2013
Completion date
February 1, 2015
Enrollment
564 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, complications, glucagon-like peptide-1, stemi - st elevation myocardial infarction